TP53 and cancer: The interruption of p53-dependent PUMA directly affects the viability of cancer cells and their chemotherapeutic resistance, while transcription factors such as p6521, FoxO3a20, p7323, and CHOP22 were also associated with PUMA initiation independent of p53 reactions [19].